These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1193 related items for PubMed ID: 15289356
1. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation. Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M. Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356 [Abstract] [Full Text] [Related]
2. Toll-like receptor signaling in anti-cancer immunity. Okamoto M, Sato M. J Med Invest; 2003 Feb 01; 50(1-2):9-24. PubMed ID: 12630564 [Abstract] [Full Text] [Related]
4. [Anti-cancer effect of an intratumoral injection of dendritic cells expressing TLR4 in combination with an active component of OK-432 in TLR4-deficient mice]. Oshikawa T, Okamoto M, Ahmed SU, Tano T, Yoshida H, Sato M. Gan To Kagaku Ryoho; 2004 Oct 01; 31(11):1770-2. PubMed ID: 15553710 [Abstract] [Full Text] [Related]
9. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Okamoto M, Oh-E G, Oshikawa T, Furuichi S, Tano T, Ahmed SU, Akashi S, Miyake K, Takeuchi O, Akira S, Himeno K, Sato M, Ohkubo S. Clin Diagn Lab Immunol; 2004 May 01; 11(3):483-95. PubMed ID: 15138173 [Abstract] [Full Text] [Related]
10. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA. Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Iida T, Yamaue H. Int J Oncol; 2008 Feb 01; 32(2):459-66. PubMed ID: 18202769 [Abstract] [Full Text] [Related]
11. Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4. Ahmed SU, Okamoto M, Oshikawa T, Tano T, Sasai A, Kan S, Hiroshima T, Ohue H, Moriya Y, Ryoma Y, Saito M, Sato M. J Immunother; 2004 Feb 01; 27(6):432-41. PubMed ID: 15534487 [Abstract] [Full Text] [Related]
13. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody. Kontani K, Teramoto K, Ozaki Y, Sawai S, Tezuka N, Ishida H, Kajino K, Fujino S, Yamauchi A, Taguchi O, Kannagi R, Yokomise H, Ogasawara K. Oncol Rep; 2007 Apr 01; 17(4):895-902. PubMed ID: 17342333 [Abstract] [Full Text] [Related]
14. [Analysis of the immuno-activation mechanism of OK-432--phagocytosis, release of active components and TLR4 signaling]. Tano T, Okamoto M, Oshikawa T, Ahmed SU, Sato M. Gan To Kagaku Ryoho; 2004 Oct 01; 31(11):1767-9. PubMed ID: 15553709 [Abstract] [Full Text] [Related]
15. [Induction of apoptosis in human head and neck cancer cell lines by an active component of OK-432 through p53-independent pathway via toll-like receptor (TLR) 4 signaling]. Tano T, Okamoto M, Oshikawa T, Ahmed SU, Sasai A, Sato M. Gan To Kagaku Ryoho; 2005 Oct 01; 32(11):1562-4. PubMed ID: 16315869 [Abstract] [Full Text] [Related]
16. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells. Okamoto M, Ohe G, Furuichi S, Nishikawa H, Oshikawa T, Tano T, Ahmed SU, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M. Anticancer Res; 2002 Oct 01; 22(6A):3229-39. PubMed ID: 12530069 [Abstract] [Full Text] [Related]